Open AccessThe significance of transarterial chemoembolization combined with systemic chemotherapy for patients with KRAS wild-type unresectable metachronous colorectal carcinoma with liver metastases
Author(s) -
Yu Qian,
Lusha Zhang,
Sunfu Fan,
Ling Huang,
Xinbao Wang,
Cai Xindun
Publication year - 2016
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.200603
Subject(s) - medicine , chemotherapy , cetuximab , carcinoembryonic antigen , univariate analysis , colorectal cancer , gastroenterology , survival rate , group b , oncology , multivariate analysis , cancer
The purpose of this study was to assess the survival benefits of transarterial chemoembolization (TACE) combined with systemic chemotherapy as the first-line treatment for metachronous unresectable colorectal carcinoma with liver metastases (CLMs) and to identify prognostic determinants.